Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report date:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted 1981
Deviations:
yes
Remarks:
no details on the composition of the adjuvant mixture; exact guideline was not mentioned ("..study was carried out as recommended in the OECD guidelines 1981...."); diet supplementation with ascorbic acid is equivocal; no details on the pilot/range finder
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
When the GPMT was performed in 1985, the LLNA did not yet exist as an OECD Testing guideline.

Test material

Constituent 1
Chemical structure
Reference substance name:
Diisopropyl 3,3'-[(2,5-dichloro-1,4-phenylene)bis[iminocarbonyl(2-hydroxy-3,1-naphthylene)azo]]bis[4-methylbenzoate]
EC Number:
275-639-3
EC Name:
Diisopropyl 3,3'-[(2,5-dichloro-1,4-phenylene)bis[iminocarbonyl(2-hydroxy-3,1-naphthylene)azo]]bis[4-methylbenzoate]
Cas Number:
71566-54-6
Molecular formula:
C50 H42 Cl2 N6 O8
IUPAC Name:
diisopropyl 3,3'-[(2,5-dichloro-1,4-phenylene)bis[iminocarbonyl(2-hydroxy-3,1-naphthylene)azo]]bis[4-methylbenzoate]
Test material form:
solid: particulate/powder
Details on test material:
- Physical state: powder
- Analytical purity: commercial grade
- Batch No.: EN 94903.52
- Storage condition of test material: room temperature
Specific details on test material used for the study:
- Physical state: powder
- Analytical purity: commercial grade
- Batch No.: EN 94903.52
- Storage condition of test material: room temperature

In vivo test system

Test animals

Species:
guinea pig
Strain:
Pirbright-Hartley
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: in-house breeding
- Age at study initiation: about 10 weeks
- Weight at study initiation: 303-426 g
- Housing: individually
- Diet (ad libitum): standard guinea pigs pellets - NAFAG No. 846, Gossau SG
- Water (ad libitum): fresh water, supplemented with fresh carrots
- Acclimation period: 8 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 2
- Humidity (%): 50 +/- 10
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: sesame oil (intradermal induction), vaseline (epicutaneous application)
Concentration / amount:
intradermal induction: 1%
epicutaneous induction: 30% (about 0.4 g/patch)
challenge: 10% (about 0.2 g/patch)
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: sesame oil (intradermal induction), vaseline (epicutaneous application)
Concentration / amount:
intradermal induction: 1%
epicutaneous induction: 30% (about 0.4 g/patch)
challenge: 10% (about 0.2 g/patch)
No. of animals per dose:
10 males and 10 females
Details on study design:
RANGE FINDING TESTS: The concentrations of the test compound for induction and challenge periods were determined on separate animals (no further information).

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1 intradermal exposure (Day 1) and 1 epicutaneous exposure (one week later)
- Exposure period: Day 1: 2 intradermal injections; Readings: 24 hours after the beginning of application. After one week: 48 hours epicutaneous exposure.
- Test groups: Intradermal: Each two injections: A) front row: 0.1 ml mixture adjuvant and saline; B) middle row : 0.1 ml of the test substance formulation in sesame oil; C) back row : 0.1 ml of the test substance formulation in the adjuvant saline mixture
Epicutaneous: about 0.4 g of the test substance incorporated in vaseline under an occlusive dressing, duration of exposure 48 hours; Readings 48 hours after the beginning of application. The application sites were pretreated the day before with 10% sodium lauryl sulfate (open application).
- Control group: Intradermal: same injections (A, B, C) but without test substance. Epicutaneous: Animals were treated analogously to the test group, but only with the solvent.
- Site: neck
- Frequency of applications: 2 intradermal injections and 1 epicutaneous exposure (see above)
- Duration: Day 1 (intradermal injection) – after one week (epicutaneous exposure)
- Concentrations: 1 % of the test substance with intradermal induction; 30 % of the test substance with epicutaneous application

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 21 days after intradermal injection
- Exposure period: 24 hours
- Test groups: about 0.2 g of the test substance (flank) under an occlusive dressing.
- Control group: animals were treated with the vehicle as well as with the test compound to control the maximal subirritant concentration of the test compound in adjuvant treated animals (no further information).
- Site: flank (the application sites where chemically depilated 3 hours before examination (Veet, about 5 minutes))
- Concentrations: 10 % of the test substance
- Evaluation (hr after challenge): 24, 48 hours after removal of the patch

OTHER: The test was carried out according to the maximization test of Magnusson and Kligman (J. invest. Dermatol. 52, 268-276, 1969).
Positive control substance(s):
yes
Remarks:
p - phenylenediamine

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0.

Any other information on results incl. tables

After occlusive epicutaneous administration, no skin reactions were found in the control and test groups.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met